With over $1.5 trillion in economic impact predicted by 2025 ( as per Gartner), emerging technologies are all set to ...

Pfizer's trailing-12-month (TTM) revenue is $59.3 billion, whereas its TTM normalized diluted earnings per share (EPS) is ...

Issues with data quality, competing projects, and high-profile executive exits are allegedly all contributing to the slowdown ...

OpenAI’s efforts to develop its next major model, GPT-5, are running behind schedule, with results that don’t yet justify the ...

The startup has run into problem after problem on its new artificial-intelligence project, code-named Orion.

*Intervals are drilled core length as insufficient drilling has been completed to calculate true widths. Andrew Thomson, President of Palamina commented: "Palamina's drilling program at Sol de Oro ...

With a market cap of $144.8 billion, New York-based Pfizer Inc. (PFE) is a global biopharmaceutical company that discovers, develops, and markets innovative medicines and vaccines across diverse ...

He pointed out the improved performance of GPT-4o, as well as OpenAI o1. Raffi also explained that people have grown more comfortable with using ChatGPT. He works with engineers who have improved ...

The Nova AI model is capable of handling a wide range of tasks across 200 languages and is expected to challenge popular large language models (LLMs) such as OpenAI’s Chat GPT and Meta Platforms ...

I expect an announcement of another year of 14 – 16% dividend growth. Pfizer got drunk on the massive revenues from the Government spending on COVID vaccines when the pandemic hit, and it’s ...

The Department of Health and Aged Care has confirmed Pfizer's JN.1 vaccine is set to be available from 9 December. The department also confirmed the immunisation guidelines will be refreshed in ...

Given how well Pfizer has performed in recent years due to its COVID-19 vaccine and pill (its revenue topped $100 billion in 2022), for many investors, it's still seen as a stock whose best days ...